ArticleJournal of medical case reports2021

Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report.

Ali McBride et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.